Evidence of increased prostate cancer detection in men aged 50 to 59: A review of 324,684 biopsies performed between 1995 and 2002

Urology

Volumn 62, Issue 6, 2003, Pages 1045-1049

  Lowe, Franklin C ^a   Gilbert, Scott M ^b   Kahane, Hillel ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; CANCER DIAGNOSIS; CANCER INCIDENCE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LABORATORY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TUMOR BIOPSY;

EID: 0344234465     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00782-9     Document Type: Article

References (17)

1. Jemal A., Thomas A., Murry T., et al. Cancer statistics, 2002. CA Cancer J Clin. 52:2002;23-47.
2. Kozlowski JM and Grayhack JT: Carcinoma of the prostate, in Gillenwater JY, Grayhack JT, Howard SS, et al (Eds): Adult and Pediatric Urology, 4th ed. Philadelphia, Lippincott Williams & Wilkins, 2002, vol 2, pp 1472-1473.
3. Hankey B.F., Feuer E.J., Clegg L.X., et al. Cancer surveillance series interpreting trends in prostate cancer - part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates . J Natl Cancer Inst. 91:1999;1017-1024.
4. Landis S.H., Murray T., Boden S., et al. Cancer statistics 1999. Cancer J Clin. 49:1999;8-31.
5. Stephenson R.A., Stanford J.L. Population-based prostate cancer trends in the Untied States patterns of change in the era of prostate-specific antigen . World J Urol. 15:1997;331-335.
6. Lodding P., Aus G., Bergdahl S., et al. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng/ml prostate specific antigen. J Urol. 159:1998;899-903.
7. Orozco R., O'Dowd G., Kunnel B., et al. Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. Urology. 51:1998;186-195.
8. Tjaden H.B., Culp D.A., Flocks R.H. Clinical adenocarcinoma of the prostate in patients under 50 years of age. J Urol. 93:1965;618-621.
9. Johnson D.E., Lanieri J.P., Ayala A.G. Prostate adenocarcinoma occurring in men under 50 years of age. J Surg Oncol. 4:1972;207-216.
10. Sandhu D.P., Munson K.W., Benghiat A., et al. Natural history and prognosis of prostate carcinoma in adolescents and men under 35 years of age. Br J Urol. 69:1992;525-529.
11. Harrison G.S. The prognosis of prostate cancer in the younger man. Br J Urol. 55:1983;315-320.
12. Aprikian A.G., Zhang Z.F., Fair W.R. Prostate adenocarcinoma in men younger than 50 years a retrospective review of 151 patients . Cancer. 74:1994;1768-1777.
13. Smith C.V., Bauer J.J., Connelly R.R., et al. Prostate cancer in men age 50 years or younger a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database . J Urol. 164:2000;1964-1967.
14. Riopel M.A., Polascik T.J., Partin A.W., et al. Radical prostatectomy in men less than 50 years old. Semin Urol Oncol. 1:1995;80-85.
15. Ruska K.M., Partin A.W., Epstein J.I., et al. Adenocarcinoma of the prostate in men younger than 40 years of age diagnosis and treatment with emphasis on radical prostatectomy findings . Urology. 53:1999;1179-1183.
16. Carter H.B., Epstein J.I., Partin A.W. Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. Urology. 53:1999;126-130.
17. Benson M.C., Kaplan S.A., Olsson C.A. Prostate cancer in men less than 45 years old influence of stage, grade and therapy . J Urol. 137:1987;888-890.